EVERAZI 500 (5 PACK) (DPCO) "AZITHROMYCIN 500mg. IP

Everazi 500 tablets contain Azithromycin 500mg for mild to moderate infections caused by susceptible bacteria. Main uses: mild to moderate community-acquired pneumonia in adults and in patients 6 months of age and older, caused by susceptible bacteria; pharyngitis and tonsillitis in adults and in patients 2 years of age and older, caused by susceptible bacteria; acute otitis media in patients 6 months of age and older, caused by susceptible bacteria; acute bacterial sinusitis in adults; acute bacterial exacerbations of chronic bronchitis in adults.

Common side effects of Everazi 500 Tablet include diarrhoea; nausea; abdominal pain; vomiting; headache; altered taste. Get medical help at once if you notice severe liver injury, including cholestatic jaundice and hepatitis; serious allergic and skin reactions, including angioedema; prolongation of the QT interval, torsades de pointes and a potential increased short-term risk of acute cardiovascular death in adults.

Each Everazi 500 tablet contains Azithromycin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Everazi 500 Tablet only as your doctor advises.

The MRP of Everazi 500 Tablet is ₹126.73 for a pack of 5x6x5 (Blister). For chemists and distributors, the PTR is ₹96.56 and the PTS is ₹86.9.

Each Everazi 500 tablet contains Azithromycin 500 mg. It comes in a pack of 5x6x5 (Blister).

Each tablet depends on azithromycin to do the work. Being a macrolide antibacterial, it stops susceptible bacteria from producing the proteins needed for growth, which holds the infection in check while the body clears it.

Must not be used in patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide drug. Must not be used in patients with a history of cholestatic jaundice or liver dysfunction linked to earlier use of azithromycin. Check with a doctor first if there is a known QT prolongation, a history of torsades de pointes or any other heart rhythm problem, or if the patient is taking other medicines that prolong the QT interval. Check with a doctor first if the patient has liver disease or myasthenia gravis. Check with a doctor first about the potential increased short-term risk of acute cardiovascular death in adults; this risk should be balanced against the treatment benefit.

Everazi 500 Tablet is a brand of Vibcare Pharma, sold through its Evermed division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.